Cargando…

Differential activation of catalase expression and activity by PPAR agonists: Implications for astrocyte protection in anti-glioma therapy()

Glioma survival is dismal, in part, due to an imbalance in antioxidant expression and activity. Peroxisome proliferator-activated receptor (PPAR) agonists have antineoplastic properties which present new redox-dependent targets for glioma anticancer therapies. Herein, we demonstrate that treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoo, Nicholas K.H., Hebbar, Sachin, Zhao, Weiling, Moore, Steven A., Domann, Frederick E., Robbins, Mike E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757675/ https://www.ncbi.nlm.nih.gov/pubmed/24024139 http://dx.doi.org/10.1016/j.redox.2012.12.006

Ejemplares similares

The regulation of catalase activity by PPAR γ is affected by α-synuclein
por: Yakunin, Eugenia, et al.
Publicado: (2014)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
por: Gurley, Catherine, et al.
Publicado: (2008)

Role of PPARs in Radiation-Induced Brain Injury
por: Ramanan, Sriram, et al.
Publicado: (2010)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
por: , Sanjay, et al.
Publicado: (2021)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

Characterization of Catalase from Psychrotolerant Psychrobacter piscatorii T-3 Exhibiting High Catalase Activity
por: Kimoto, Hideyuki, et al.
Publicado: (2012)

APPARATUS FOR MEASUREMENT OF OXIDASE AND CATALASE ACTIVITY
por: Harvey, R. B.
Publicado: (1920)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
por: McAleer, Jeremy P.
Publicado: (2023)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

The Effect of the Degree of Homogenization on the Catalase Activity of Liver “Homogenates”
por: Adams, D. H., et al.
Publicado: (1957)

Synthesis and Biological Activity of Piperine Derivatives as Potential PPARγ Agonists
por: Wang, Yanli, et al.
Publicado: (2020)

PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes
por: Santambrogio, Paolo, et al.
Publicado: (2023)

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
por: Stunes, Astrid K, et al.
Publicado: (2011)

Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects
por: Jani, Rajendra H., et al.
Publicado: (2013)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Growth-Dependent Catalase Localization in Exiguobacterium oxidotolerans T-2-2(T) Reflected by Catalase Activity of Cells
por: Hanaoka, Yoshiko, et al.
Publicado: (2013)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
por: Belfiore, A., et al.
Publicado: (2009)

Genes Important for Catalase Activity in Enterococcus faecalis
por: Baureder, Michael, et al.
Publicado: (2012)

Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo
por: Du, Lingyao, et al.
Publicado: (2017)

Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ
por: Ma, Liang, et al.
Publicado: (2016)

Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition
por: Tian, Siyu, et al.
Publicado: (2021)

An investigation of the relation between catalase C262T gene polymorphism and catalase enzyme activity in leukemia patients
por: Eras, Nazan, et al.
Publicado: (2019)

Autoantibody–Abzymes with Catalase Activity in Experimental Autoimmune Encephalomyelitis Mice
por: Urusov, Andrey E., et al.
Publicado: (2023)

Epigenetic Determinants of CYP1A1 Induction by the Aryl Hydrocarbon Receptor Agonist 3,3',4,4',5-Pentachlorobiphenyl (PCB 126)
por: Vorrink, Sabine U., et al.
Publicado: (2014)

PPAR Agonists and Cardiovascular Disease in Diabetes
por: Calkin, Anna C., et al.
Publicado: (2008)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Is Root Catalase a Bifunctional Catalase-Peroxidase?
por: Chioti, Vasileia, et al.
Publicado: (2017)

Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes
por: Schnegg, Caroline I., et al.
Publicado: (2011)

Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-γ, RAR and RXR Agonists
por: Sharvit, Efrat, et al.
Publicado: (2013)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020)

Data supporting the spectrophotometric method for the estimation of catalase activity
por: Hadwan, Mahmoud Hussein, et al.
Publicado: (2015)

Antioxidant Activity of SOD and Catalase Conjugated with Nanocrystalline Ceria
por: Gil, Dmitry, et al.
Publicado: (2017)

Nanocomposite films as electrochemical sensors for detection of catalase activity
por: Johnson, Dwight, et al.
Publicado: (2022)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR-γ Agonist Lowers Triglyceride Independently of PPAR-α Activation
por: Chandalia, Apurva, et al.
Publicado: (2009)

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
por: Scatena, Roberto, et al.
Publicado: (2008)

Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma
por: Grimaldi, Alfonso, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ebp7eepmnhdognbsjsd9b2c6cf